PTEN acts as an essential negative regulator of the PI3K/AKT/mTOR signaling pathway to suppress cell growth and survival, whereas loss of PTEN, frequently seen in human cancers, results in hyperactivation of the PI3K/AKT/mTOR pathway to promote growth and survival of cancer cells [29]. This evidence concerns the gene AKT1 and cancer.